chenodeoxycholic acid has been researched along with Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Abraham, DJ; Lin, HR | 1 |
| Bazin, MA; Clément, M; Descamps, G; El Kihel, L; Khalid, M; Rault, S | 1 |
| Huang, TL; Mayence, A; Vanden Eynde, JJ | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Luo, G; Mu, Q; Pan, L; Xu, N; Yao, S; Yu, M; Yu, Y | 1 |
3 review(s) available for chenodeoxycholic acid and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Some non-conventional biomolecular targets for diamidines. A short survey.
Topics: Amidines; Animals; Diabetes Mellitus, Type 2; DNA; Enzymes; Humans; Hypertension; Ion Channels; Myotonic Dystrophy; Neoplasms; Neurodegenerative Diseases; Proteins; RNA; Thrombosis | 2014 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
3 other study(ies) available for chenodeoxycholic acid and Neoplasms
| Article | Year |
|---|---|
Identification of a lead pharmacophore for the development of potent nuclear receptor modulators as anticancer and X syndrome disease therapeutic agents.
Topics: Antineoplastic Agents; Cell Line; Chemistry, Pharmaceutical; Chenodeoxycholic Acid; DNA-Binding Proteins; Drug Design; Genes, Reporter; Humans; Metabolic Syndrome; Models, Chemical; Models, Molecular; Neoplasms; Protein Binding; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Transcriptional Activation; Transfection; Two-Hybrid System Techniques | 2006 |
New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines.
Topics: Amides; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Chenodeoxycholic Acid; Colonic Neoplasms; DNA Fragmentation; Glioblastoma; Humans; Lithocholic Acid; Multiple Myeloma; Neoplasms; NF-kappa B; Piperazines; Signal Transduction | 2008 |
Expression of flTF and asTF splice variants in various cell strains and tissues.
Topics: Alternative Splicing; Apolipoproteins M; Caco-2 Cells; Cell Proliferation; Chenodeoxycholic Acid; Female; Humans; Male; Neoplasms; Neovascularization, Pathologic; Protein Isoforms; RNA Splicing; Thromboplastin | 2019 |